T. Rowe Price Associates’s Akcea Therapeutics, Inc. Common Stock AKCA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-955,568	Closed	-$26.4M	–	2620
2017 Q3	$26.4M	Buy	+955,568	New	+$26.4M	﹤0.01%	1076